Answers are grounded in this paper and cite their sources.
Results of this study show that cerebral 5-HT4 receptor binding was lower in patients with MDD than in healthy controls and that the memory dysfunction in patients with MDD was associated with lower cerebral 5-HT4 receptor binding. The cerebral 5-HT4 receptor is a promising treatment target for memory dysfunction in patients with MDD.
No takes yet. Share an insight, caveat, or question.
Köhler‐Forsberg et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: